CFDE Data Portal | Search WWP2

	Label	Description
	WWP2 Gene (Entity type)	ENSG00000198373 - WW domain containing E3 ubiquitin protein ligase 2
	WWP2 associations Collection (Entity type)	Associations for WWP2_associations
	WWP2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	WWP2 MOUSE Protein (Entity type)	NEDD4-like E3 ubiquitin-protein ligase WWP2
	WWP2 HUMAN Protein (Entity type)	NEDD4-like E3 ubiquitin-protein ligase WWP2
	GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207871 NPC knockdown S18 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 14 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

WWP2

ENSG00000198373 - WW domain containing E3 ubiquitin protein ligase 2

WWP2 associations

Associations for WWP2_associations

WWP2 associations.tsv

A file from IDG as part of the Harmonizome project

WWP2 MOUSE

NEDD4-like E3 ubiquitin-protein ligase WWP2

WWP2 HUMAN

NEDD4-like E3 ubiquitin-protein ligase WWP2

GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE207871 NPC knockdown S18 1 v 0 human up

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 14 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.